Artivion Correlations

AORT Stock  USD 24.42  0.26  1.08%   
The current 90-days correlation between Artivion and Orthofix Medical is 0.49 (i.e., Very weak diversification). The correlation of Artivion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Artivion Correlation With Market

Modest diversification

The correlation between Artivion and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Artivion and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artivion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Artivion Stock please use our How to Invest in Artivion guide.

Moving together with Artivion Stock

  0.76DH Definitive Healthcare Buyout TrendPairCorr
  0.65EKSO Ekso Bionics HoldingsPairCorr
  0.71ELAB Elevai Labs, Common Upward RallyPairCorr
  0.89ELMD Electromed Potential GrowthPairCorr
  0.67EMBC Embecta CorpPairCorr
  0.93ENOV Enovis CorpPairCorr
  0.75WORX Scworx CorpPairCorr
  0.68FIGS Figs IncPairCorr
  0.64AMS American Shared Hospital Earnings Call This WeekPairCorr
  0.76XAIR Beyond AirPairCorr

Moving against Artivion Stock

  0.6CI Cigna CorpPairCorr
  0.6FEMY FemasysPairCorr
  0.32ESTA Establishment LabsPairCorr
  0.82BKD Brookdale Senior LivingPairCorr
  0.65BAX Baxter InternationalPairCorr
  0.57CHE Chemed CorpPairCorr
  0.55DGX Quest DiagnosticsPairCorr
  0.46CVS CVS Health Corp Aggressive PushPairCorr
  0.4ABT Abbott LaboratoriesPairCorr
  0.31COR CencoraPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SRDXSGHT
CNMDAVNS
ELMDOFIX
CNMDSRDX
CNMDSGHT
AVNSOFIX
  
High negative correlations   
CNMDLUNG
AXGNSGHT
ELMDLUNG
LUNGAVNS
SRDXAXGN
LUNGSGHT

Risk-Adjusted Indicators

There is a big difference between Artivion Stock performing well and Artivion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Artivion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANIK  1.48  0.02  0.00 (0.08) 0.00 
 2.82 
 14.59 
SGHT  3.26 (0.36) 0.00 (0.44) 0.00 
 7.19 
 24.66 
OFIX  1.23 (0.05) 0.00 (0.16) 0.00 
 2.18 
 6.60 
AVNS  1.40 (0.27) 0.00 (0.41) 0.00 
 2.61 
 13.49 
AXGN  2.64  0.47  0.19  0.51  2.38 
 5.97 
 21.80 
LUNG  3.37  0.42  0.14 (3.45) 3.34 
 6.59 
 41.39 
ELMD  2.33 (0.14) 0.00 (0.22) 0.00 
 3.90 
 21.31 
SRDX  1.45 (0.42) 0.00 (0.84) 0.00 
 1.74 
 10.84 
NUVA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CNMD  1.64 (0.20) 0.00 (0.33) 0.00 
 3.52 
 13.79 

Artivion Corporate Management

Daniel BevevinoIndependent DirectorProfile
Jean HollowaySenior Vice President Chief Compliance Officer, General Counsel, SecretaryProfile
Jon SalvesonIndependent DirectorProfile
Andrew GreenVice President - Regulatory AffairsProfile
Thomas AckermanIndependent DirectorProfile
Rochelle ManeyVice President - Global Quality AssuranceProfile